Variables | Total (n = 6140) | FIB-L (n = 2069) | FIB-M (n = 2033) | FIB-H (n = 2038) | P value |
---|---|---|---|---|---|
Age, years | 58.4 ± 10.4 | 57.3 ± 10.2 | 58.2 ± 10.2 | 59.6 ± 10.6 |  < 0.001 |
Male, % | 4771 (77.7) | 1729(83.6) | 1567(77.1) | 1475(72.4) |  < 0.001 |
BMI, kg/m2 | 25.9 ± 3.2 | 25.7 ± 3.1 | 26.1 ± 3.2 | 25.9 ± 3.3 |  < 0.001 |
Diabetes mellitus, % | 1862 (30.3) | 521(25.2) | 656(32.3) | 685(33.6) |  < 0.001 |
Hypertension, % | 3930 (64.0) | 1248(60.3) | 1328(65.3) | 1354(66.4) |  < 0.001 |
Dyslipidemia, % | 4241 (69.1) | 1403(67.8) | 1436(70.6) | 1402(68.8) | 0.140 |
Family history of CAD, % | 1433 (23.3) | 501(24.2) | 479(23.6) | 453(22.2) | 0.309 |
Smoking, % | 3496 (56.9) | 1197(57.9) | 1173(57.7) | 1126(55.3) | 0.169 |
Prior MI, % | 1219 (19.9) | 465(22.5) | 394(19.4) | 360(17.7) |  < 0.001 |
Prior PCI or CABG, % | 1581 (25.7) | 621(30.0) | 514(25.3) | 446(21.9) |  < 0.001 |
Prior stroke, % | 658 (10.7) | 204(9.9) | 206(10.1) | 248(12.2) | 0.033 |
Clinical presentation, % |  < 0.001 | ||||
 SAP | 2572 (41.9) | 995 (48.1) | 874 (43.0) | 703 (34.5) |  |
 ACS | 3568 (58.1) | 1074 (51.9) | 1159 (57.0) | 1335 (65.5) |  |
 LVEF, % | 63.0 ± 7.2 | 63.6 ± 6.8 | 63.5 ± 6.8 | 62.0 ± 7.9 |  < 0.001 |
 FBG, mmol/L | 6.1 ± 2.0 | 5.8 ± 1.8 | 6.1 ± 2.0 | 6.3 ± 2.2 |  < 0.001 |
 HbA1c, % | 6.6 ± 1.2 | 6.4 ± 1.0 | 6.6 ± 1.2 | 6.8 ± 1.4 |  < 0.001 |
 FIB, mg/dL | 3.40 ± 0.84 | 2.62 ± 0.28 | 3.26 ± 0.17 | 4.32 ± 0.74 |  < 0.001 |
 hs-CRP, mg/L | 3.14 ± 3.77 | 1.31 ± 1.74 | 2.34 ± 2.65 | 5.81 ± 4.64 |  < 0.001 |
 D-dimer, μg/mL | 0.41 ± 0.65 | 0.37 ± 0.70 | 0.38 ± 0.52 | 0.48 ± 0.70 |  < 0.001 |
 TC, mmol/L | 4.17 ± 1.09 | 4.00 ± 1.07 | 4.21 ± 1.08 | 4.30 ± 1.11 |  < 0.001 |
 HDL-C, mmol/L | 1.02 ± 0.28 | 1.02 ± 0.27 | 1.03 ± 0.28 | 1.00 ± 0.28 | 0.060 |
 LDL-C, mmol/L | 2.48 ± 0.92 | 2.34 ± 0.91 | 2.50 ± 0.91 | 2.59 ± 0.93 |  < 0.001 |
 TG, mmol/L | 1.81 ± 1.12 | 1.75 ± 1.12 | 1.85 ± 1.13 | 1.83 ± 1.12 | 0.015 |
 Creatinine (μmol/L) | 75.4 ± 16.0 | 74.5 ± 14.1 | 74.6 ± 15.4 | 77.0 ± 18.2 |  < 0.001 |
 Lesion vessels | 1.4 ± 0.7 | 1.4 ± 0.6 | 1.4 ± 0.7 | 1.5 ± 0.7 |  < 0.001 |
 LM/three-vessel disease, % | 2773 (45.2) | 865 (41.8) | 909 (44.7) | 999 (49.0) |  < 0.001 |
 SYNTAX scorea | 12.0 ± 8.2 | 11.2 ± 7.8 | 11.9 ± 8.2 | 12.8 ± 8.5 |  < 0.001 |
 Complete revascularization, % | 3310 (53.9) | 1201 (58.0) | 1090 (53.6) | 1019 (50.0) |  < 0.001 |
 Number of stents | 1.8 ± 1.2 | 1.8 ± 1.1 | 1.8 ± 1.2 | 1.9 ± 1.2 | 0.148 |
 DES implantation, % | 5778 (94.1) | 1941 (93.8) | 1923 (94.6) | 1914 (93.9) | 0.520 |
Medications at discharge, % | |||||
 Aspirin | 6077 (99.0) | 2051(99.1) | 2011(98.9) | 2015(98.9) | 0.680 |
 Clopidogrel | 6020 (98.0) | 2023(97.8) | 1997(98.2) | 2000(98.1) | 0.542 |
 β-blocker | 5609 (91.4) | 1878(90.8) | 1868(91.9) | 1863(91.4) | 0.443 |
 ACEI/ARB | 3150 (51.3) | 983(47.5) | 1049(51.6) | 1118(54.9) |  < 0.001 |
 CCB | 2875 (46.8) | 952(46.0) | 973(47.9) | 950(46.6) | 0.482 |
 Statin | 5923 (96.5) | 2002(96.8) | 1963(96.6) | 1958(96.1) | 0.473 |
 Nitrate | 5984 (97.5) | 2021(97.7) | 1981(97.4) | 1982(97.3) | 0.683 |